Letter by Ma et al Regarding Article, "Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial"

Circulation. 2017 May 16;135(20):e1042-e1043. doi: 10.1161/CIRCULATIONAHA.116.027072.

Authors

Lei-Lei Ma¹, Fei-Juan Kong¹, Jun-Bo Ge¹

Affiliation

¹ From Shanghai Institute of Cardiovascular Diseases and Institute of Panvascular Medicine, Zhongshan Hospital, Fudan University, China (L.-L.M., J.-B.G.); Department of Critical Care Medicine, Zhejiang Provincial People's Hospital and People's Hospital of Hangzhou Medical College, China (L.-L.M.); and Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, China (F.-J.K.).

PMID: 28507254
DOI: 10.1161/CIRCULATIONAHA.116.027072

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Exenatide*
Glucagon-Like Peptide 1*
Humans
Hypoglycemic Agents
Neuroprotective Agents
Out-of-Hospital Cardiac Arrest

Substances

Hypoglycemic Agents
Neuroprotective Agents
Glucagon-Like Peptide 1
Exenatide